Ionmax is proud to announce that the Ionmax+ AIRE and AIRE X air purifiers have been approved by the Sensitive Choice program. This recognition underscores the products' effectiveness in creating healthier indoor environments, particularly for those with asthma and allergies.
The Sensitive Choice program, an initiative of the National Asthma Council Australia, identifies products and services that may benefit people with asthma and allergies. The approval of Ionmax+ AIRE and AIRE X air purifiers signifies their compliance with strict standards and their potential to improve air quality for sensitive individuals.
Ray Smith, Business Development Manager of Ionmax, expressed his enthusiasm about the approval: "This recognition validates our commitment to producing high-quality air purification solutions that genuinely make a difference in people's lives."
Consumers, especially those with respiratory sensitivities, often look for products that have been independently assessed and approved. The Sensitive Choice badge on Ionmax+ AIRE and AIRE X air purifiers will provide customers with added confidence in their purchasing decisions.
Smith added: "In today's world, where indoor air quality is of paramount importance, having the Sensitive Choice seal of approval sets our products apart and assures customers that they're investing in a solution that can truly benefit their health and wellbeing."
The Ionmax+ AIRE and AIRE X air purifiers feature advanced 6-stage filtration technology, including two HEPA filters, which effectively remove airborne particles, allergens, and pollutants. These models also boast some of the highest clean air delivery rates in Australia at 900 and 1000 cubic metres per hour, purifying spaces of up to 234 and 260 square metres, respectively.
The addition of the AIRE and AIRE X air purifiers further expands Ionmax's range of Sensitive Choice approved products, which already consists of domestic desiccant dehumidifiers, reinforcing the brand's commitment to providing solutions that cater to those with asthma and allergies.
